Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
322 participants
OBSERVATIONAL
2019-11-01
2020-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
NCT01056367
Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus
NCT00298844
Thyroid Function and Diabetes Complications
NCT03001336
Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes
NCT01128205
Early Identification of Heart Failure in a High-Risk Diabetic Cohort
NCT05866380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a descriptive cross-sectional study, which included 322 type -2 diabetic patients (37 male, 63 female) who were presented to our center from November 2019 to January 2020.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Male and Female
(37 male, 63 female)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed Diabetics
* known case of diabetes
Exclusion Criteria
* Pregnant women
* Type-1 diabetic patients,
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kabul University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Habib Ahmad Esmat
Research committee
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad wali Nasary, MD
Role: PRINCIPAL_INVESTIGATOR
KMUs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Habib Ahmad Esmat
Kabul, None Selected, Afghanistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.